Apps for Next Forward BIOLABS ICP Open May 26
Forward BIOLABS will be accepting applications for Round 2 of its Innovation to Commercialization Pipeline (ICP) Program between May 26 and June 19, the company announced recently. ICP will continue…
Category Archives: Biotech
FUJIFILM CDI Opens New Manufacturing Facility
FUJIFILM Cellular Dynamics Inc. (FCDI) opened its new headquarters and iPSC development and manufacturing facility at 8402 Excelsior Dr. on Tuesday, the company announced recently. According to a release, the…
BioForward Wisconsin CEO to Retire
BioForward Wisconsin CEO Lisa Johnson is set to retire at the end of 2026, the organization announced recently. Johnson has been the CEO for the past 11 years and played…
Cellectar Biosciences Gives Report on Clinical Trial
Cellectar Biosciences announced updated and mature 12-month follow-up data from its Phase 2b CLOVER WaM clinical trial evaluating iopofosine I 131 in patients with relapsed or refractory Waldenstrom macroglobulinemia, the…
Elephas Collaborates With Mithrl
Elephas is collaborating with Mithrl, an AI company focused on accelerating research through its Scientific Decision Engine (SDE), the company announced recently. “Partnering with Mithrl enables us to more fully…
NorthStar Secures FDA Acceptance of N.C.A. Ac-225
Northstar Medical Radioisotopes received notice of U.S. Food & Drug Administration (FDA) acceptance of its Type II Drug Master File (DMR) submission for the company’s no-carrier-added (n.c.a.) Actinium-225 (Ac-225), the…
SHINE Gets Conditional Commitment for $265M DOE Loan
SHINE has received a conditional commitment for a loan of $263 million from the U.S. Department of Energy’s (DOE) Office of Energy Dominance Financing, the company announced today. According to…
SHINE, C-Ray Therapeutics Partner
SHINE Technologies has entered a supply agreement with C-Ray Therapeutics, a global radiopharmaceutical CRDMO, the company announced recently. According to a release, C-Ray will supply SHINE’s n.c.a. Lu-177 to Chinese…
BrainXell Launches iPSC-Derived Sensory Neurons
BrainXell is launching its human induced pluripotent stem cell (iPSC)-derived sensory neurons, the company announced recently. According to a release, the iPSC-derived sensory neurons are a scalable human cellular platform…
SHINE Technologies Raises $240M
SHINE Technologies has raised $240 million in equity funding, the company announced recently. The round was led by NantWorks with additional participation from Fidelity Management & Research Company, Sumitomo Corporation of…
